UBS Group AG - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 86 filers reported holding SEELOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$410
-85.1%
2,226
-3.1%
0.00%
Q2 2023$2,746
+78.5%
2,298
+3.2%
0.00%
Q1 2023$1,538
-76.8%
2,226
-77.2%
0.00%
Q4 2022$6,626
-72.4%
9,743
-58.7%
0.00%
Q3 2022$24,000
+1100.0%
23,585
+959.5%
0.00%
Q2 2022$2,000
-33.3%
2,226
-39.9%
0.00%
Q1 2022$3,000
-95.7%
3,703
-91.5%
0.00%
Q4 2021$70,000
+900.0%
43,540
+1332.7%
0.00%
Q3 2021$7,0003,039
+7692.3%
0.00%
Q2 2021$0
-100.0%
39
-99.5%
0.00%
Q1 2021$43,0008,627
+22020.5%
0.00%
Q4 2020$039
+5.4%
0.00%
Q3 2020$0
-100.0%
37
-99.0%
0.00%
Q2 2020$4,000
-33.3%
3,678
-70.9%
0.00%
Q1 2020$6,00012,650
+1264900.0%
0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$0
-100.0%
1
-99.9%
0.00%
Q1 2019$3,0009530.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders